The Beginnings of Konan Medical 1947

Konan Medical Inc. in Japan (“KMI”), was established in 1947 in Hyogo Japan after WWII by a group of camera enthusiasts.

KMI has been in the specular microscope business since 1979 and holds over 1,600 patents including many remarkable products such as the balloon camera (meteorology) 1955, radar camera 1956, electrofax copy machine 1960, the first disposable camera 1963, and the specular microscope 1979.

As the market leader in specular microscopy, Konan has a significant share of the healthy and growing market for devices used to image and assess the corneal endothelium both for clinical and donor corneas / eye banking.

Constant innovation of a rock-solid product is the foundation for its well-earned leadership position in specular microscopy and fierce customer loyalty over years.

Konan`s Focus

With a focus on innovative diagnostic devices, Konan Medical`s flagship specular microscopes are globally recognized by eye care professionals, regulatory groups, professional reading centers, and clinical trials experts as the "Gold Standard" for endothelial cell density and morphometric analysis.

The Company`s product portfolio extends into high-precision, military-grade color vision diagnostics and contrast sensitivity testing, objective assessment of visual pathway function using VEP and ERG, objective pupillometry and objective perimetry.

Konan Medical continues to earn its solid position in the marketplace with core strengths of clinical evidence collection, imaging and eye tracking, renowned customer support, expert service, and innovative competence in engineering, manufacturing and software development.

Konan`s Market Position

Konan Medical USA, Inc. (KMUI) has a global sales and distribution channel comprised of in-house, virtual and geographically distributed direct sales, seasoned sales representatives, and distributors with extensive eye care product experience. Today there are over 20,000 Konan-branded products (KMI and KMUI) in use in 60 countries worldwide and in all 50 states in the USA.

Konan Medical`s clinical trials services program counts a large percentage of FDA registered manufacturers of ophthalmic implantable devices and pharmaceuticals as customers.

Additionally, Konan is the market-leader in the donor cornea tissue / eye bank specular microscopy segment.

Intellectual Property

Konan Medical USA, Inc has over 26 issued patents in 9 countries and 8 Pending applications. Fields of coverage include objective perimetry, pupillometry, ocular motor function, concussion-related wearables, VEP + ERG electrodes, color vision and contrast sensitivity, and other objective visual functional diagnostics.

Business Development & Investment

The Company`s core activities include actively searching for promising new technologies to complement its existing products, and leveraging its medical device infrastructure including global regulatory, R&D, sales and marketing, customer service, and clinical trials support services. Explore opportunities by contacting Charles Stewart (CEO) | Dale Sadlik (COO).

CellChek 20 Table Unboxing - Video